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Abstract
The association between oral lichen planus (OLP) and hypothyroidism has been debated 
with conflicting results: some authors detected a statistically significant association 
between these two, while others did not confirm it. The aim of this study was to 
evaluate the thyroid status in patients with newly diagnosed OLP to test the null 
hypothesis that thyroid disease is not associated with an increased incidence of oral 
lesions, with a prospective case-control approach. A total of 549 patients have been 
evaluated, of whom 355 were female. Odds ratio (OR) and 95% confidence intervals 
(CIs) were obtained. Patients suffering from thyroid diseases were associated with an 
almost 3-fold increased odds of having OLP (OR 2.85, 95% CI: 1.65–4.94), after adjusting 
this analysis for age, gender, body mass index, smoking status, diabetes, hypertension 
and hepatitis C infection. It would be appropriate to further investigate the possible 
concomitance of OLP among patients with thyroid disorder; endocrinologists should be 
aware of this association, especially because OLP is considered a potentially malignant 
oral disorder.
Introduction
Oral lichen planus (OLP) is a common immune-mediated 
mucocutaneous disorder, usually described among females 
between the fifth and the sixth decades; the estimated 
worldwide prevalence is reported between 0.22 and 5%, 
with an average value of 1–2% (1). The exact aetiology 
still remains unknown, although immune dysregulation 
seems to play a critical role in the development and 
progression of OLP, with such disease being the ultimate 
outcome of interaction between the immune system and 
a varied range of extrinsic antigens and/or altered self-
antigens (2).
The OLP clinical forms are usually classified as 
follows: (a) white lichen (WL), which included the 
papular, reticular and plaque forms; (b) red lichen 
(RL), which included all the atrophic or erosive forms, 
irrespective of a contemporaneous presence of a white 
form (1). It has been supposed that these different clinical 
manifestations may be related to dissimilar biological 
events; furthermore, a significant involvement of specific 
classes of T-lymphocytes, responsible of marked tissue 
damage, could determine the development of erosive 
lesions (3).
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In the last decade, some authors have reported a 
statistically significant association between OLP and 
hypothyroidism (4, 5, 6) or Hashimoto’s thyroiditis (7), 
while other studies denied it (8).
Considering all the previous deliberations, in such a 
discordant context, we decided to assess the association of 
OLP with some comorbidities, focusing our attention on 
thyroid diseases, with a case-control approach.
Study design and methods
Our study is a prospective analysis, conducted on a 
comprehensive sample collected from the Caucasian 
population residing in Piedmont, Northwest Italy; only 
patients older than 18 years were selected, while pregnant 
or breast-feeding women were excluded.
The case group consisted of 307 OLP patients 
attending the Oral Medicine Unit, C.I.R. Dental School, 
between January 2015 and May 2017. According to 
accepted standards (1), the diagnosis of OLP was based 
on the following criteria: (a) presence of characteristic 
bilateral clinical signs (papular and/or reticular lesions 
alone or in association with atrophic or erosive lesions); 
(b) histological confirmation of clinical diagnosis through 
incisional biopsy demonstrating the presence of a well-
defined band-like zone of cellular infiltration, consisting 
mainly of lymphocytes, confined to the superficial 
part of the connective tissue and signs of ‘liquefaction 
degeneration’ in the basal cell layer; (c) absence of signs 
of epithelial dysplasia at the moment of first diagnosis; (d) 
and absence of suspicion that oral lesions may be related 
to any drug or oral restoration.
In the same period, a sample of 242 healthy controls 
with no clinically detectable oral lesions, unrelated to 
the cases, were recruited from the population attending 
two dental private practices in need of an oral implant 
rehabilitation.
All procedures followed were in accordance with the 
ethical standards of the responsible committee on human 
experimentation (institutional and national) and with the 
Helsinki Declaration of 1975, as revised in 2008. The study 
was approved by the ethical committee of the CIR-Dental 
School. Consent was obtained after full explanation of the 
purpose and nature of all procedures used.
At baseline, anamnestic data were collected, focusing 
on pre-existing or coexisting systemic diseases and daily 
medications. In particular, the prevalence of diabetes, 
hepatitis C (HCV) infection, hypertension and thyroid 
disease was thoroughly detailed. Moreover, thyroid 
function tests (free thyroxin (fT4) and thyroid-stimulating 
hormone (TSH)) were required after the baseline 
examination of the oral cavity. The reference ranges, 
to consider normal function of the thyroid gland, were 
between 9.0 and 25.0 pmol/L for fT4, and between 0.4 
and 4.0 milliunits per litre (U/L) for TSH. Patients with 
the abnormal test were referred to an endocrinologist. 
Levothyroxine was the most commonly reported 
prescribed medication in our sample.
The primary aim of this study was to describe the 
thyroid status both in patients with OLP and healthy 
controls to test the null hypothesis according to which 
OLP is not associated with an increased incidence of 
thyroid disease.
Quantitative variables were described via means, 
standard deviations (s.d.), medians, first and third 
quartiles (Q1 and Q3), qualitative ones via frequencies 
and percentages. The Gaussian distributions of the 
continuous variables were verified via Kolmogorov–
Smirnov tests. Due to the non-Gaussian distribution of 
the medians, their differences were tested using Kruskal–
Wallis tests. Chi-squared tests were performed to evaluate 
differences in qualitative variables; meanwhile, if the 
values were expected to be less than 5, Fisher’s exact tests 
were performed. Then, odds ratios (ORs) and their 95% 
confidence intervals (95% CIs) were obtained computing 
two multivariable logistic regression models. The first one 
was adjusted for age, gender, body mass index (BMI) and 
smoking status; the second one was adjusted for diabetes, 
hypertension and HCV infection. All statistical analyses 
were performed using SAS-ver.9.3, and a 2-tailed P-value 
less than 0.05 was considered statistically significant.
Results
A total of 549 patients have been evaluated, of whom 355 
were female (f/m = 1.83/1). Table 1 summarises the main 
characteristics of cases and controls. On the one hand, 
the two groups were similar for age, gender and habit 
of smoking: average age was 58 years for both samples, 
with s.d. = 13.5 for cases and s.d. = 10.5 for controls. 
Furthermore, 14.9% of the cases were smokers, with a 
mean of nine cigarettes per day, while in the control group, 
18.7% smoked an average of thirteen cigarettes per day. 
On the other hand, prevalence of overweight, diabetes, 
hypertension and thyroid diseases was statistically higher 
in cases than controls (Table 1).
Table  2 reports thyroid disorders and evaluation of 
serological analyses between cases and controls. At the 
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time of OLP diagnosis, 64 patients reported a positive 
anamnestic record of pre-existing thyroid disease, whereas 
only 7 were later found to have irregular thyroid function 
tests, and consequently referred to a specific unit in order 
to make the proper diagnosis. Conversely, none of the 
control group was diagnosed with any kind of thyroid 
condition after the enrolment. Comparing these data, 
OLP patients were found to be statistically more exposed 
to a thyroid disease underdiagnosed at baseline (P = 0.003 
with Fisher’s test) than controls.
Seventy-one (23.1%) OLP patients were finally 
found to have a specific thyroid problem, in comparison 
to only 22 (9.1%) control patients. In detail for OLP 
patients, twenty-eight (39.4%) of them had a diagnosis 
of hypothyroidism, which was iatrogenic in nine patients 
– due to either thyroidectomy or treatment with I-131 – 
post-infectious in two cases, not otherwise specified in the 
remaining seventeen individuals. Thirty patients reported 
a previously diagnosed Hashimoto’s thyroiditis (HT). 
Nine cases suffered from nodular thyroid disease, such as 
diffused goitre (no. 5), single nodule (no. 3) or multiple 
nodules (no. 1). Finally, 3 patients had Graves–Basedow 
disease, whilst 1 had a non-specified hyperthyroidism. 
Concerning the distribution of these specific disorders, 
no differences were detected between cases and controls 
(Table 2). Moreover, no statistical differences were found 
in terms of serological thyroid values or reported therapy 
with levothyroxine as prescribed by the specialist (Table 2).
Figure  1 and Table  3 describe the multivariable 
model used to make the logistic regression, by means 
of the 2 models previously explained. When compared 
with controls, patients with thyroid problems were 
associated with an almost 3-fold increased odds of having 
OLP (regarding the types); the difference was indeed 
statistically significant if adjusted for age, gender, BMI 
and smoke (OR 2.71, 95% CI: 1.58–4.65), and also if 
adjusted for diabetes, hypertension and HCV infection 
(OR 2.85, 95% CI: 1.65–4.94). Similar data have also been 
detected if considering patients with only hyperkeratotic 
lesions (WL); moreover, if considering only RL patients, 
this risk was found to be even higher. Otherwise, no 
difference in risk was assessed between patients with RL 
and those with WL.
Table 1 Demographical and clinical characteristics of the 
studied groups (OLP: oral lichen planus).
 
 
 
OLP patients no. 307 (100%)
Control patients 
no. 242 (100%)
Gender
Male 104 (33.9%) 90 (37.2%)
Female 203 (66.1%) 152 (62.8%)
 P-value§ = 0.40  
Age 
Mean (s.d.) 58.3 (13.5) 58.0 (10.5)
Median (Range) 59 (50; 68) 59.0 (52; 66)
 P-valueç = 0.50  
Concomitant extra-oral manifestation due to lichen planus
Skin 23 (7.5%) –
Genital 20 (6.5%) –
Scalp 3 (1%) –
Nail 1 (0.3%) –
Body mass index
Mean (s.d.) 25.7 (4.4) 24.2 (4.2)
Median (Range) 25.0 (22.6; 28.3) 23.8 (21.1; 26.6)
 P-value§ = 0.0001  
Smoking status
No 261 (85%) 197 (81.4%)
 P-value§ = 0.26  
Hypertension
Yes 117 (38.1%) 65 (26.9%)
 P-value§ = 0.005  
Diabetes
Yes 36 (11.7%) 14 (5.8%)
 P-value§ = 0.02  
Hepatitis C infection
Yes 8 (2.6%) 2 (0.8%)
 P-value* = 0.12  
Thyroid diseases
Yes 71 (23.1%) 22 (9.1%)
 P-value§ = 0.0001  
P-value: *Fisher’s test; §chi-squared test; çKruskall–Wallis test.
Table 2 Description of reported thyroid problems and 
evaluation of serological analyses (OLP: oral lichen planus; 
P-value: Fisher’s test).
 
 
 
 
OLP patients no. 307 
(100%)
Control 
patients no. 
242 (100%)
TSH
Normal 291 (94.8%) 229 (94.6%)
Low 3 (1.0%) 1 (0.4%)
Elevated 13 (4.2%) 12 (5.0%)
 P-value = 0.78  
fT4
Normal 303 (98.7%) 241 (99.6%)
Low 4 (1.3%) 0 (0%)
Elevated 0 (0%) 1 (0.4%)
 P-value = 0.08  
Thyroid disease positive patients
 No. 71 (/307) No. 22 (/242)
Nodular thyroid diseases 9 (12.7%) 3 (13.6%)
Hyperthyroidism 4 (5.6%) 1 (4.6%)
Autoimmune 
hypothyroidism
30 (42.3%) 11 (50%)
Not autoimmune 
hypothyroidism
28 (39.4%) 7 (31.8%)
 P-value = 0.91  
Patients on active treatment for hypothyroidism at baseline
 No. 51 (/64) No. 18 (/22)
 P-value = >0.99  
This work is licensed under a Creative Commons 
Attribution-NonCommercial 4.0 International 
License.
Research P G Arduino et al. Hypothyroidism and oral 
lichen
En
d
o
cr
in
e 
C
o
n
n
ec
ti
o
n
s
6:729729–730
DOI: 10.1530/EC-17-0262
http://www.endocrineconnections.org © 2017 The authors
Published by Bioscientifica Ltd
Discussion
To the best of our knowledge, this is the largest prospective 
study ever published reporting the possible positive 
relationship between OLP and thyroid diseases.
The prevalence of thyroid dysfunction could differ 
within different populations and countries, occurring 
most frequently in ageing women (9, 10), but recent 
epidemiological data from our territory have been 
collected, reporting an overall crude prevalence of 
31.1/1000 (2.3/1000 for iatrogenic hypothyroidism) 
and an overall crude incidence of 7/1000 (11). Our data 
reported an incidence of thyroid disease of 23% which is 
unconfutably higher also considering those values.
The idea of a possible association between OLP and 
thyroid diseases has originated from previous reports of 
patients who were found to be affected by OLP as well as 
thyroid diseases.
Usually, patients with any kind of autoimmune 
disease are more susceptible to other types of 
autoimmune disorders; however, such tendency varies 
according to many factors, such as the prevalence 
and incidence of that disease (8). Due to its immune-
mediated pathogenesis, the possibility of an association 
between OLP and concurrent autoimmune conditions, 
such as thyroid diseases, can be speculated. In our 
series, almost half of thyroid pathologies among OLP 
patients had an autoimmune aetiology (i.e. HT and 
Graves–Basedow disease). Immune-mediated diseases, 
such as OLP, have multifactorial aetiology, including 
genetic predisposition; it has been reported that some 
common alleles may be involved in the development of 
OLP as well as HT (7). To this date, there is no conclusive 
hypothesis that could explain the coexistence of OLP 
and HT. However, recently Lo Muzio and co-workers 
suspected a causal or predisposing role of HT in 
OLP patients, by suggesting that circulating thyroid 
antibodies could contribute to trigger an organ-specific 
autoimmune response also in the oral mucosa or skin, 
leading to the development of LP lesions. In contrast, 
other authors found no relationship between HT and 
OLP (8), but those data arose from a retrospective study 
in which the diagnosis of OLP was not always performed 
histologically; moreover, that study was conducted 
Control subjects
(n=242)
WL OLP
(n=200)
RL OLP
(n=107)OLP (n=307)
OR= 2.85 (1.65-4.94)
OR= 2.71 (1.47-4.99)
OR= 3.42 (1.73-6.77)
OR= 1.45 (0.80-2.64)
Figure 1
Analysis between differences in thyroid disease positivity for OLP patients 
vs patients with no oral lesions, adjusted for age, gender, BMI, smoke, 
diabetes, hypertension and HCV infection.
Table 3 Logistic regression models to analyse differences in thyroid disease positivity for oral lichen planus (OLP) patients and 
negative control cases (OLP patients also divided in those with white lesions (WL) or red lesions (RL)).
 Model 1 OR (95% IC) Model 2 OR (95% IC)
Patients with OLP vs patients without OLP (307 vs 242)
 Negative thyroid disease (236 vs 220) Ref. Ref.
 Positive thyroid disease (71 vs 22) 2.71 (1.58–4.65) 2.85 (1.65–4.94)
Patients with WL OLP vs patients without OLP (200 vs 242)
 Negative thyroid disease (159 vs 220) Ref. Ref.
 Positive thyroid disease (41 vs 22) 2.44 (1.35–4.40) 2.71 (1.47–4.99)
Patients with RL OLP vs patients without OLP (107 vs 242)
 Negative thyroid disease (77 vs 220) Ref. Ref.
 Positive thyroid disease (30 vs 22) 3.32 (1.72–6.42) 3.42 (1.73–6.77)
Patients with RL OLP vs patients with WL OLP (107 vs 200)
 Negative thyroid disease (77 vs 159) Ref. Ref.
 Positive thyroid disease (30 vs 41) 1.40 (0.78–2.53) 1.45 (0.80–2.64)
*Model 1: adjusted for age, gender, BMI, and smoke. Model 2: adjusted also for diabetes, hypertension, and HCV infection.
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in an Iranian sample, where genetic and ethnical 
idiosyncrasies might have played a role in the outcomes, 
as well.
Some authors have suggested that the association 
between OLP and hypothyroidism could be linked to 
an unidentified common immune-mediated process, 
justifying the need for further studies regarding such 
intriguing theory (6). Differently, nodular thyroid diseases 
have no autoimmune aetiology; yet, immunological 
alterations such as an increased number of dendritic 
cells, an increased number of circulating lymphocytes 
and production of inflammatory mediators like IL-6 and 
TNF-α, also involved in OLP pathogenesis, have been 
detected (5).
In light of the above, we decided to consider thyroid 
diseases as a whole: concerning this matter, we did not 
find statistically significant differences in the incidence of 
OLP lesions between autoimmune and nodular thyroid 
disorders (data not shown; P-value > 0.05). Similar data 
have also been obtained in a recent prospective case-
control study, even though no case of autoimmune 
thyroid disorder has been reported; however, also based 
on the findings of the present study, it is likely to assume 
that patients with OLP could suffer from thyroid disease 
more frequently than the general population, particularly 
from hypothyroidism (4).
Considering these results, especially among 
Caucasian Northern Italian patients diagnosed with 
thyroid diseases, it would be appropriate to investigate 
the possible coexistence of OLP, through specialist 
counselling. Endocrinologists should be aware of this 
association, mainly because OLP should be considered 
as an oral potentially malignant disorder that requires 
regular follow-up over time (12).
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